• ProKidney Announces $62 Million Acquisition of inRegen americanpharmaceuticalreview
    January 15, 2019
    ProKidney announces the acquisition of inRegen and its affiliate, Twin City Bio. ProKidney was founded by a group of investors led by Pablo Legorreta, the Founder and CEO of Royalty Pharma.....
PharmaSources Customer Service